THE PROGNOSTIC ROLE OF ERCC1 IN ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW & META-ANALYSIS

Por Roth, Joshua A., Carlson, Josh J.
Publicado em 2011

The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis

Por Carlson, Josh J., Roth, Joshua A.
Publicado em 2013

Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer

Por Roth, Joshua A., Ramsey, Scott D., Carlson, Josh J.
Publicado no Oncologist (2015)

Understanding the Economic Value of Molecular Diagnostic Tests: Case Studies and Lessons Learned

Por Towse, Adrian, Ossa, Diego, Veenstra, David, Carlson, Josh, Garrison, Louis
Publicado no J Pers Med (2013)

Use of Epidermal Growth Factor Receptor Mutation Analysis in Patients with Advanced Non-Small-Cell Lung Cancer to Determine Erlotinib Use as First-Line Therapy

Por Ishibe, Naoko, Carlson, Josh, Ramsey, Scott David, Freedman, Andrew, Schully, Sheri
Publicado em 2011

Paying for personalized care: Cancer biomarkers and comparative effectiveness

Por Thariani, Rahber, Veenstra, David L., Carlson, Josh J., Garrison, Louis P., Ramsey, Scott
Publicado em 2012

Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses

Por Rouzier, Roman, Pronzato, Paolo, Chéreau, Elisabeth, Carlson, Josh, Hunt, Barnaby, Valentine, William J.
Publicado em 2013

Cost-Effectiveness of a 14-Gene Risk Score Assay to Target Adjuvant Chemotherapy in Early Stage Non-Squamous Non-Small Cell Lung Cancer

Por Roth, Joshua A., Billings, Paul, Ramsey, Scott D., Dumanois, Robert, Carlson, Josh J.
Publicado em 2014

An Evaluation of the Potential Cost-Effectiveness of Noninvasive Testing Strategies in the Diagnosis of Significant Liver Fibrosis

Por Carlson, Josh, Kowdley, Kris V., Sullivan, Sean D., Ramsey, Scott D., Veenstra, David L.
Publicado em 2009

Comparative Effectiveness of Biomarkers to Target Cancer Treatment: Modeling Implications for Survival and Costs

Por Birnbaum, Jeanette K., Ademuyiwa, Foluso O., Carlson, Josh J., Mallinger, Leslie, Mason, Mark W., Etzioni, Ruth
Publicado no Med Decis Making (2015)

Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research

Por Esmail, Laura C., Roth, Josh, Rangarao, Sneha, Carlson, Josh J., Thariani, Rahber, Ramsey, Scott D., Veenstra, David L., Deverka, Patricia
Publicado no Genet Med (2012)

Stakeholder Assessment of the Evidence for Cancer Genomic Tests: Insights from Three Case Studies

Por Deverka, Patricia A., Schully, Sheri D., Ishibe, Naoko, Carlson, Josh J., Freedman, Andrew, Goddard, Katrina A.B., Khoury, Muin J., Ramsey, Scott D.
Publicado no Genet Med (2012)

Value of Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics

Por Carlson, Josh J., Thariani, Rahber, Roth, Josh, Gralow, Julie, Henry, N. Lynn, Esmail, Laura, Deverka, Pat, Ramsey, Scott D., Baker, Laurence, Veenstra, David L.
Publicado em 2013

Prioritization in Comparative Effectiveness Research: The CANCERGEN Experience in Cancer Genomics

Por Thariani, Rahber, Wong, William, Carlson, Josh J, Garrison, Louis, Ramsey, Scott, Deverka, Patricia A, Esmail, Laura, Rangarao, Sneha, Hoban, Carolyn J, Baker, Laurence H, Veenstra, David L
Publicado em 2012